{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T12:11:19Z","timestamp":1777896679399,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.acuroe.2026.501905","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T16:16:04Z","timestamp":1767629764000},"page":"501905","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The impact of multidisciplinary team meetings on the management of metastatic prostate cancer in a reference center"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5151-658X","authenticated-orcid":false,"given":"L.A.","family":"Pereira do Nascimento","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.M.","family":"Mariano da Costa Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Ramos Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.J.","family":"Saab Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.H.","family":"Bueno Bavaresco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Panhoca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Aparecido Fran\u00e7a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.A.","family":"Seabra Rios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Pinheiro Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acuroe.2026.501905_bib0005","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/COC.0b013e318243708f","article-title":"Impact of a Prostate Multidisciplinary Clinic program on patient treatment decisions and on adherence to NCCN guidelines","volume":"36","author":"Korman","year":"2013","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.acuroe.2026.501905_bib0010","author":"Cornford"},{"key":"10.1016\/j.acuroe.2026.501905_bib0015","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70020","article-title":"Cancer mortality by country of birth and cancer type in Sweden: a 25\u2010year registry\u2010based cohort study","volume":"13","author":"Tollosa","year":"2024","journal-title":"Cancer Med"},{"key":"10.1016\/j.acuroe.2026.501905_bib0020","doi-asserted-by":"crossref","DOI":"10.5123\/S1679-49742019000100008","article-title":"Preval\u00eancia e fatores associados \u00e0 fragilidade em popula\u00e7\u00e3o idosa do Sul do Brasil, 2014*","volume":"28","author":"Far\u00edas-Ant\u00fanez","year":"2019","journal-title":"Epidemiol Serv Sa\u00fade"},{"key":"10.1016\/j.acuroe.2026.501905_bib0025","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.eururo.2020.09.046","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II\u20142020 update: treatment of relapsing and metastatic prostate cancer","volume":"79","author":"Cornford","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2026.501905_bib0030","doi-asserted-by":"crossref","first-page":"479","DOI":"10.6004\/jnccn.2019.0023","article-title":"Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology","volume":"17","author":"Mohler","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.acuroe.2026.501905_bib0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12913-020-4930-3","article-title":"The impact of tumor board on cancer care: evidence from an umbrella review","volume":"20","author":"Specchia","year":"2020","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.acuroe.2026.501905_bib0040","doi-asserted-by":"crossref","DOI":"10.1590\/0100-6991e-20223150","article-title":"Desfechos cl\u00ednicos dos pacientes com Tumores de p\u00e2ncreas discutidos em Tumor Board","volume":"49","author":"Silva","year":"2022","journal-title":"Rev Col Bras Cir"},{"key":"10.1016\/j.acuroe.2026.501905_bib0045","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1590\/1806-9282.66.4.419","article-title":"Multidisciplinary teams: perceptions of professionals and oncological patients","volume":"66","author":"Tanaka","year":"2020","journal-title":"Rev Assoc Med Bras"},{"key":"10.1016\/j.acuroe.2026.501905_bib0050","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12301-024-00415-4","article-title":"The impact of uro-oncology multidisciplinary team meeting (MDTM) on clinical decision-making and adherence to MDTM recommendation: experience from a tertiary referral centre in Malaysia","volume":"30","author":"Amat","year":"2024","journal-title":"Afr J Urol"},{"key":"10.1016\/j.acuroe.2026.501905_bib0055","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1056\/NEJMoa1503747","article-title":"Chemohormonal therapy in metastatic hormone-sensitive prostate cancer","volume":"373","author":"Sweeney","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acuroe.2026.501905_bib0060","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1056\/NEJMoa1704174","article-title":"Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer","volume":"377","author":"Fizazi","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acuroe.2026.501905_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejon.2021.102032","article-title":"Exploring the impact of uro-oncology multidisciplinary team meetings on patient outcomes: a systematic review","volume":"54","author":"Askelin","year":"2021","journal-title":"Eur J Oncol Nurs"},{"key":"10.1016\/j.acuroe.2026.501905_bib0070","doi-asserted-by":"crossref","first-page":"e2718","DOI":"10.1136\/bmj.e2718","article-title":"Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women","volume":"344","author":"Kesson","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.acuroe.2026.501905_bib0075","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/pros.24167","article-title":"Dynamic multidisciplinary team discussions can improve the prognosis of metastatic castration\u2010resistant prostate cancer patients","volume":"81","author":"Zhu","year":"2021","journal-title":"Prostate"},{"issue":"S1","key":"10.1016\/j.acuroe.2026.501905_bib0080","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/bju.12764","article-title":"Uro\u2010oncology multidisciplinary meetings at an Australian tertiary referral centre \u2013 impact on clinical decision\u2010making and implications for patient inclusion","volume":"114","author":"Rao","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.acuroe.2026.501905_bib0085","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.healthpol.2014.09.006","article-title":"Is it worth reorganising cancer services on the basis of multidisciplinary teams (MDTs)? A systematic review of the objectives and organisation of MDTs and their impact on patient outcomes","volume":"119","author":"Prades","year":"2015","journal-title":"Health Policy (New York)"},{"key":"10.1016\/j.acuroe.2026.501905_bib0090","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.lungcan.2008.01.008","article-title":"Systematic review of multidisciplinary teams in the management of lung cancer","volume":"60","author":"Coory","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1016\/j.acuroe.2026.501905_bib0095","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1038\/bjc.2013.586","article-title":"A study of the decision outcomes and financial costs of multidisciplinary team meetings (MDMs) in oncology","volume":"109","author":"De Ieso","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.acuroe.2026.501905_bib0100","first-page":"1","article-title":"The overall survival and safety of men with metastatic hormone-sensitive prostate cancer treated with combination therapy of novel androgen receptor antagonists and androgen-deprivation therapy: a systematic review and meta-analysis","volume":"2022","author":"Wu","year":"2022","journal-title":"J Oncol"},{"key":"10.1016\/j.acuroe.2026.501905_bib0105","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/oncolo\/oyad045","article-title":"Real-world treatment trends among patients with metastatic castration-sensitive prostate cancer: results from an international study","volume":"28","author":"Barata","year":"2023","journal-title":"Oncologist"},{"key":"10.1016\/j.acuroe.2026.501905_bib0110","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ctrv.2015.11.007","article-title":"The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: a systematic review of the literature","volume":"42","author":"Pillay","year":"2016","journal-title":"Cancer Treat Rev"}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578626000132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578626000132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:34:05Z","timestamp":1777624445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173578626000132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2173578626000132"],"URL":"https:\/\/doi.org\/10.1016\/j.acuroe.2026.501905","relation":{},"ISSN":["2173-5786"],"issn-type":[{"value":"2173-5786","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of multidisciplinary team meetings on the management of metastatic prostate cancer in a reference center","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuroe.2026.501905","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2025.501905","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AEU. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"501905"}}